China generally requires PCT national phase entry within 30 months from the priority date, with Chinese translations and CNIPA formalities. CNIPA materials also describe late entry up to 32 months with a surcharge in specified circumstances.
| Patent office | China National Intellectual Property Administration (CNIPA) |
|---|---|
| Entry deadline | 30 months from the priority date; CNIPA materials describe late entry before 32 months with the applicable surcharge. |
| Language / translation | Chinese translation is required for the international application content specified by CNIPA. |
| Representation | Foreign applicants should confirm current CNIPA representation requirements and typically work through qualified Chinese patent counsel for filing and prosecution. |
| Portfolio question | China can be strategically important where sales, manufacturing, supply chains, competitors or licensing activity are concentrated in China. |
This page separates current national-phase procedure from strategic filing considerations. Deadlines, fees and office rules can change, so consequential filing decisions should be verified against the official sources listed below.
A PCT application seeking patent protection in China must complete CNIPA national-phase formalities. The international application does not automatically become a Chinese patent application merely because China was designated under the PCT. National entry requires the prescribed documents, translation and fees.
CNIPA states that the normal time limit for national-phase entry is 30 months from the priority date. The filing plan should treat this as a hard internal control and start translation and local instructions well in advance because Chinese-language preparation can take significant time for long technical specifications.
CNIPA guidance provides an important jurisdiction-specific feature: if the necessary acts were not completed within the 30-month period, entry may still be completed before 32 months from the priority date with the applicable surcharge. This is not a reason to plan late filing; it is a limited safety mechanism that should be verified against the current rules for the specific case.
CNIPA requires Chinese translations of the relevant application material. The translation can include the description, claims, drawing text and abstract, with treatment of Article 19 or Chapter II amendments depending on the case. Technical translation should be reviewed for terminology consistency because later prosecution will operate from the Chinese text.
CNIPA identifies specific forms and documents for international applications entering the Chinese national phase. Foreign applicants typically coordinate national entry through Chinese patent professionals who manage filing formalities, translation review, examination requests and office-action responses.
Once in China, prosecution proceeds under Chinese patent law and CNIPA examination practice. International search results can provide useful context but do not predetermine the outcome. Applicants should consider China-specific inventive-step, support, amendment and claim-format issues when preparing the national-stage strategy.
China may have strategic importance even where it is not the applicant's largest sales market. Manufacturing, assembly, component sourcing and competitor operations can create enforcement and licensing value. Country selection should therefore consider where the invention is made and supplied, not only where finished products are sold.
Key cost variables include official fees, Chinese translation, local patent counsel, examination, responses to office actions and later annual fees. Long applications and large claim sets can increase translation and prosecution expense. A budget should therefore distinguish entry-stage cost from full lifecycle cost.
China is strongest as a portfolio jurisdiction where the applicant has meaningful market, manufacturing, licensing, supply-chain or competitor exposure. The filing decision should also account for expected claim scope, technology field, evidence quality and long-term enforcement strategy.
Before entering the national phase in China, re-check the controlling deadline, translation requirements, required application documents, representation rules, official fees and any available restoration or extension mechanism against the current patent-office or WIPO materials linked on this page. A national-phase decision should also confirm that the application being entered is the correct international application and that the claims, description and drawings support the commercial product. Procedural accuracy and portfolio value are separate questions, so both should be reviewed before fees are committed.
Entry into China should be tied to a commercial reason. Relevant evidence can include expected revenue, manufacturing, technically significant infrastructure, competitors, licensees, investors, regulated-market access and the location of acts that could support infringement evidence. A large market is not automatically a high-value patent market for every invention. The strongest decision record states what commercial leverage the right is expected to create and what portfolio cost will be required through prosecution and maintenance.
The PCT application may contain broad claims, but the commercially useful position in China can depend on who performs the claimed steps and how the product is deployed. Server-side, device, system, composition, method or manufacturing claims can create different enforcement positions depending on the technology. Before examination begins, identify the product features that matter, the likely competitor implementation and the evidence that could later show use of the claimed invention.
The national-phase deadline is not only a procedural event. It is a natural point to review product-market fit, licensing discussions, competitor activity, financing, technical changes and prior-art developments. If the invention has changed materially since the priority filing, prosecution strategy should be adjusted within the support available in the original disclosure. Jurisdictions that no longer support a clear business objective can be removed, allowing budget to move toward stronger markets or newer inventions.
Before acting on this page, identify the exact decision it is meant to support, the official source that controls any procedural requirement, the technical or commercial evidence that justifies the chosen jurisdiction, and the next deadline or document required. A clear decision record should also state what would cause the strategy to change. This makes the research usable during later prosecution, national-phase selection, budgeting and portfolio review rather than leaving it as a static summary.
Before acting on this page, identify the exact decision it is meant to support, the official source that controls any procedural requirement, the technical or commercial evidence that justifies the chosen jurisdiction, and the next deadline or document required. A clear decision record should also state what would cause the strategy to change. This makes the research usable during later prosecution, national-phase selection, budgeting and portfolio review rather than leaving it as a static summary.
Before acting on this page, identify the exact decision it is meant to support, the official source that controls any procedural requirement, the technical or commercial evidence that justifies the chosen jurisdiction, and the next deadline or document required. A clear decision record should also state what would cause the strategy to change. This makes the research usable during later prosecution, national-phase selection, budgeting and portfolio review rather than leaving it as a static summary.
Use official filing rules together with market, manufacturing, competitor, licensing, enforcement and technology considerations before committing to long-term prosecution cost.
rd (at) patentbusinesslawyer (dot) com
